However, much less progress has been made in combating metastasis—the ability of cancer cells to migrate to different parts of the body and establish new tumors. Metastasis remains the primary ...

In the US, for example, overall incidence, mortality and, in particular, morbidity from cancer ... of therapies tested in patients with metastatic cancer (where they are partly successful but ...

Metastasis causes >90% of cancer death. The emergence, persistence, therapy resistance and lethality of metastatic cancer is driven by dynamic and tenacious metastasis stem cells (MetScs). The Ganesh ...

Read the full article. 3. Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases This April article reported a downward trend in morbidity and ...

Ninety percent of cancer deaths are due to the spread of cancer, not complications from the original tumor. Thus, for over 50 years now, scientists have been on a quest to identify which malignant ...

This will shed fresh light on the pathology of ovarian cancer, a disease that is characterised by rapid metastasis and high morbidity,” Ramray Bhat, Associate Professor at the Department of ...

Initial data suggests clodronate (clodronic acid) reduces the incidence of both osseous and visceral metastases in high-risk patients with breast cancer. In addition, like other bisphosphonates ...

Cancer screening is key to saving patients' lives since an earlier stage diagnosis improves survival rates, decreases morbidity, and leads to less intensive treatments.

China NMPA approves Astellas Pharma’s Padcev in combination with Keytruda to treat advanced bladder cancer: Tokyo Thursday, January 9, 2025, 09:00 Hrs [IST] Astellas Pharma Inc.